Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00087334 | Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 1 / Phase 2 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00070122 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | terminated | Phase 3 | 2,200 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 |
| NCT00070265 | Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer | terminated | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00047333 | Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed | terminated | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00061958 | Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01619696 | Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas | terminated | Phase 2 | 3 | University Hospital, ToulouseOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00052585 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00087191 | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | terminated | N/A | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00699374 | Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer | terminated | Phase 3 | 1,075 | PfizerINDUSTRY | 23 | Jan 14, 2013 | clinicaltrials |
| NCT01611506 | Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer | terminated | Phase 1 / Phase 2 | 1 | Dr Anna Dorothea WagnerOTHER | 1 | Jan 9, 2013 | clinicaltrials |
| NCT00087256 | Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer | terminated | Phase 3 | 18 | NSABP Foundation IncNETWORK | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00288444 | Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer | terminated | Phase 1 | 38 | Emory UniversityOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01071434 | Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors | terminated | — | 5 | Stanford UniversityOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00966251 | Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma | terminated | Phase 1 / Phase 2 | 2 | CureTech LtdINDUSTRY | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | terminated | Phase 2 | 191 | PfizerINDUSTRY | 4 | Oct 11, 2012 | clinicaltrials |
| NCT00004099 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | terminated | Phase 3 | 144 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | terminated | Phase 2 | 119 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | terminated | Phase 2 / Phase 3 | 88 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00410774 | Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery | terminated | Phase 1 / Phase 2 | 20 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 3 | 1,035 | AbbottINDUSTRY | 29 | Sep 10, 2012 | clinicaltrials |
| NCT00080002 | Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction | terminated | Phase 2 | — | Enzon Pharmaceuticals, Inc.INDUSTRY | 0 | Sep 6, 2012 | clinicaltrials |
| NCT00855634 | Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München(PaMeViTUM) | terminated | N/A | 355 | Technical University of MunichOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00469963 | Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery | terminated | N/A | 12 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT00335959 | S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 7 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00760604 | A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer | terminated | Phase 3 | 4 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 13, 2012 | clinicaltrials |
| NCT00828620 | Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project | terminated | — | 21 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT01238653 | Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures | terminated | — | 8 | Pathfinder TherapeuticsINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00426829 | Proton Therapy and Bevacizumab for Primary Liver Tumors | terminated | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00062023 | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | terminated | Phase 2 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00030511 | Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer | terminated | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 16, 2012 | clinicaltrials |
| NCT00368329 | Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer | terminated | Phase 1 | 4 | Stanford UniversityOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00562666 | Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells(ICAR) | terminated | Phase 1 | 2 | Rennes University HospitalOTHER | 1 | Jun 22, 2012 | clinicaltrials |
| NCT01197820 | Hepatic and Renal Thermography Using Magnetic Resonance Imaging(THeR-IRM) | terminated | N/A | 15 | University Hospital, BordeauxOTHER | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | terminated | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00618384 | TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)(SOCRATES) | terminated | Phase 2 | 43 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT01056809 | Treatment Strategies for Primarily Generalized Colorectal Cancer(PGC) | terminated | N/A | 15 | Vrinnevi HospitalOTHER | 1 | May 31, 2012 | clinicaltrials |
| NCT00006269 | Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | terminated | Phase 3 | 89 | NovartisINDUSTRY | 1 | May 25, 2012 | clinicaltrials |
| NCT00767468 | Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis | terminated | Phase 1 | 6 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT00466856 | Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | terminated | Phase 2 | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT01262183 | Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus(PANORAMIC) | terminated | Phase 2 | 4 | Radboud University Medical CenterOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00824161 | Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer | terminated | Phase 2 | 28 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 23, 2012 | clinicaltrials |
| NCT01109615 | Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations(PG) | terminated | Phase 2 | 40 | Vejle HospitalOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00495625 | Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) | terminated | Phase 2 | 33 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT01337492 | Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT) | terminated | Early Phase 1 | 2 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 21, 2012 | clinicaltrials |
| NCT00873002 | Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01126450 | Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | terminated | Phase 2 | 20 | Galectin Therapeutics Inc.INDUSTRY | 2 | Mar 6, 2012 | clinicaltrials |
| NCT00532987 | Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer | terminated | — | 22 | Stanford UniversityOTHER | 1 | Feb 28, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Feb 1, 2013source: clinicaltrials